Exchange: OTC·Updated 09:30 AM EDT
About TTIPF
Thiogenesis Therapeutics Corp. engages in the development of novel drug formulations that act as precursors for rare diseases. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada.